RBC Capital Maintains Outperform on Aveanna Healthcare Hldgs, Lowers Price Target to $9
RBC Capital analyst Ben Hendrix maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Outperform and lowers the price target from $16 to $9.
Stephens & Co. Maintains Overweight on Aveanna Healthcare Hldgs, Lowers Price Target to $7
Stephens & Co. analyst Scott Fidel maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight and lowers the price target from $11.5 to $7.
Credit Suisse Maintains Outperform on Aveanna Healthcare Hldgs, Lowers Price Target to $9.5
Credit Suisse analyst Nick Giovacchini maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Outperform and lowers the price target from $12 to $9.5.
Mid-Afternoon Market Update: Dow Surges 250 Points; NeoGenomics Shares Slide
U.S. stocks traded higher toward the end of trading, with the Dow jumping over 250 points on Tuesday.
Mid-Day Market Update: Crude Oil Down 2.5%; IGM Biosciences Shares Jump
U.S. stocks traded higher midway through trading, with the Dow jumping over 250 points on Tuesday.
36 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) jumped 88.1% to $0.38 after declining 9% on Monday.
Here’s Why Aveanna Healthcare Shares Are Falling
Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) shares are trading lower by 26.2% at $3.98 after the company reported FY21 EPS results were down from last year. The company also issued FY22 sales guidance below analyst estimates.
Mid-Morning Market Update: Markets Open Higher; McCormick Profit Beats Estimates
U.S. stocks opened on a strong note on Tuesday, with the Dow jumping around 350 points this morning.